Tachycardial arrhythmic disorder. not every arrhythmia requires treatment
Odenthal, H.J.; Wiechmann, H.W.
Medizinische Monatsschrift für Pharmazeuten 10(11): 348-352
1987
ISSN/ISBN: 0342-9601 PMID: 3696062 Document Number: 294982
Document emailed within 1 workday
Related Documents
Blaabjerg, M.; Marjanovic, D. 2013: Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment Ugeskrift for Laeger 175(5): 285-286Haverkamp, W.; Wichter, T.; Chen, X.; Hördt, M.; Willems, S.; Rotman, B.; Hindricks, G.; Kottkamp, H.; Borggrefe, M.; Breithardt, G. 1994: The pro-arrhythmic effects of anti-arrhythmia agents Zeitschrift für Kardiologie 83(Suppl 5): 75-85
Jaillon, P.; Simon, T. 1992: Ventricular pro-arrhythmic effects of anti-arrhythmia drugs Therapie 47(3): 187-192
Mest, H.J.; Blass, K.E.; Förster, W. 1976: The anti-arrhythmic effect of prostaglandins A1, E1, A2, E2 and F2a in the cat strophanthin arrhythmia model Acta Biologica et Medica Germanica 35(1): 63-67
Urbaszek, W.; Günther, K. 1975: Methods of simple electric stimulation in the treatment of tachycardial arrhythmias Zeitschrift für Arztliche Fortbildung 69(24): 1274-1278
Libersa, C.; Caron, J.; Guedon-Moreau, L.; Lacroix, D. 1992: Pro-arrhythmic effects of anti-arrhythmic agents. Study methods and difficulties in analysis Therapie 47(5): 363-365
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Kesteloot, H. 1974: General aspects of anti-arrhythmic treatment with aprindine Acta Cardiologica Suppl 18: 303-316
Bredikis, Y.Y.; Vashkialite, I.V. 1989: Tachycardial disorders of cardiac rhythm as a cause of left ventricular dysfunction Cor et Vasa 31(2): 110-117
Saito, T. 2013: Evaluation and treatment of development disorder with mood disorder Seishin Shinkeigaku Zasshi 115(6): 657-663
Hørby, H.R.ør.æk. 2014: Risk also requires treatment Ugeskrift for Laeger 176(12)
Broustet, P.; Daubeze, J.; Giraudet, C.; Clementy, J.; Fourcade, J.P.; Choussat, A. 1974: Application anti-arrhythmic properties of amiodarone to the treatment of atrial disease Therapie 29(1): 131-136
Touboul, P. 1993: Non-pharmacological treatment of ventricular tachycardia (anti-arrhythmic surgery excluded) Archives des Maladies du Coeur et des Vaisseaux 86(5 Suppl): 809-817
Molinis, G.; Valente, M.; Tuniz, D.; Maisano, G. 1982: Propafenone: a new anti-arrhythmic drug for treatment of ectopic ventricular beats Cardiologia 27(2): 211-217
Mélon, P. 2011: Perspectives and recommendations for the anti-arrhythmic treatment of atrial fibrillation: focus on dronedarone Revue Medicale de Liege 66(3): 159-163
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Skolnick, A. 1990: New York law requires treatment of some but not all hepatitis B-exposed newborns JAMA 264(10): 1234
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123